Q3 2020 Holdings
Filed 2020-11-16 | 36 holdings | $6.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $5.5M | 2,153,265 | 81.8% |
| BioNTech SE(BNTX) | SPONS ADS | 09075V102 | $879.0K | 12,700 | 13.0% |
| Forma Therapeutics Holdings, Inc. | COM | 34633R104 | $74.4K | 1,492,163 | 1.1% |
| Nkarta, Inc.(NKTX) | COM | 65487U108 | $61.2K | 2,034,703 | 0.9% |
| Iveric Bio, Inc.(OPHTEUR) | COM | 46583P102 | $19.0K | 3,370,478 | 0.3% |
| Springworks Therapeutics Inc | COM | 85205L107 | $19.0K | 398,017 | 0.3% |
| CureVac N.V. | COM | N2451R105 | $17.2K | 370,385 | 0.3% |
| Sutro BioPharma Inc | COM | 869367102 | $16.8K | 1,675,579 | 0.2% |
| Intercept Pharmaceuticals Inc(ICPTUSD) | COM | 45845P108 | $16.7K | 403,688 | 0.2% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $15.7K | 192,334 | 0.2% |
| Unum Therapeutics, Inc. | COM | 903214104 | $13.3K | 5,681,818 | 0.2% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $11.6K | 1,407,949 | 0.2% |
| Odonate Therapeutics Inc | COM | 676079106 | $11.0K | 815,421 | 0.2% |
| Atreca Inc(BCELUSD) | COM | 04965G109 | $8.6K | 617,560 | 0.1% |
| Verona Pharma Plc.(VRNA) | SPONS ADS | 925050106 | $6.9K | 1,111,112 | 0.1% |
| Aeglea BioTherapeutics, Inc.(AGLEUSD) | COM | 00773J103 | $6.3K | 883,720 | 0.1% |
| Equillium, Inc.(EQ) | COM | 29446K106 | $6.2K | 1,074,285 | 0.1% |
| Bctg Acquisition Corp | COM | 05492W103 | $5.2K | 500,000 | 0.1% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $5.1K | 234,846 | 0.1% |
| Panacea Acquisition Corp. | UNIT | 698102209 | $4.8K | 400,000 | 0.1% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $4.3K | 494,190 | 0.1% |
| Kala Pharmaceuticals Inc | COM | 483119103 | $3.4K | 451,162 | 0.1% |
| Albireo Pharma, Inc.(BDQM) | COM | 01345P106 | $3.3K | 100,000 | 0.0% |
| Genron Corporation(GERN) | COM | 374163103 | $2.7K | 1,531,088 | 0.0% |
| Allovir, Inc | COM | 019818103 | $2.5K | 91,057 | 0.0% |
| Novavax, Inc.(NVAX) | COM | 670002401 | $2.3K | 21,660 | 0.0% |
| Fulcrum Therapeutics, Inc.(FULC) | COM | 359616109 | $2.3K | 294,118 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $2.3K | 99,643 | 0.0% |
| Aimmune Therapeutics, Inc.(AIMT) | COM | 00900T107 | $2.0K | 58,142 | 0.0% |
| Catabasis Pharmaceuticals Inc(CATBEUR) | COM | 14875P206 | $1.9K | 300,000 | 0.0% |
| Spero Therapeutics, Inc.(SPRO) | COM | 84833T103 | $1.8K | 160,000 | 0.0% |
| Urovant Sciences Ltd | COM | G9381B108 | $1.5K | 157,480 | 0.0% |
| Hookipa Pharma Inc | COM | 43906K100 | $1.1K | 116,602 | 0.0% |
| KalVista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.1K | 84,087 | 0.0% |
| NGM Biopharmaceuticals, Inc.(NGMUSD) | COM | 62921N105 | $580 | 36,451 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $105 | 25,000 | 0.0% |